back to
back to

Program: Monday (25.10.2010)

08:30 – 10:00

Room: Großer Saal

Scientific Session Basic Research

  • Andreas Rosenwald
  • Margaret Shipp

  • Pathogenesis of HL

    • Ralf Küppers

  • cHL and Microenvironment

    • Randy Gascoyne

  • Rationale for Non-Genotoxic Treatment

    • Stephan Mathas

  • From High Dimensional Data to Disease Mechanisms – NOTCH Signaling in Hodgkin Lymphoma

    • Karl Köchert

  • The Role of miRNAs in Hodgkin Lymphoma

    • Anke van den Berg

  • Methylation Pro ling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

    • Franziska Eberle

10:30 – 12:00

Room: Großer Saal

Scientific Session Early Stages

  • Anton Hagenbeek
  • Richard Hoppe

  • Actions Following the Interim Analysis of the EORTC/GELA/IIL Intergroup H10 Trial

    • John Raemaekers

  • Debate: Role of Radiotherapy in Early Favorable HL

    • George Canellos
    • Anton Hagenbeek
    • Joachim Yahalom

  • State of the Art and Future Perspectives

    • Andreas Engert

  • Early FDG-PET Scan Con rms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients

    • Luigi Rigacci

  • Involved Node Radiotherapy Signi cantly Reduces Lung, Breast and Thyroid Dose in Patients with Limited Stage Hodgkin Lymphoma

    • Belinda Campbell

10:30 – 12:00

Room: Kleiner Saal

Workshop Pediatric HL

  • Judith Landman-Parker
  • Cindy L. Schwartz

  • Early Response-Based HL Therapies of the COG

    • Cindy L. Schwartz

  • Update on EuroNet-PHL-C1 trial

    • Dieter Körholz

  • Hodgkin Lymphoma therapy in Central America

    • Pedro De Alarcon

  • Involved Level 3-D Based Target Volume Concepts for Pediatric Hodgkin Lymphoma

    • Lütgendorf-Caucig

  • Update on LPHL

    • Judith Landman-Parker

  • Panel Discussion

    • Louis S. Constine
    • Dieter Körholz
    • Judith Landman-Parker
    • Cindy L. Schwartz

12:00 – 14:00

Room: Großer Saal

Satellite Symposium State-of-the-Art and Future Approaches

  • Andreas Engert
  • Michael Hallek

  • Lunch

  • Hodgkin Lymphoma

    • Peter Borchmann

  • Chronic Lymphatic Leukemia

    • Michael Hallek

  • Follicular Lymphoma

    • Gilles Salles

14:00 – 15:30

Room: Großer Saal

Scientific Session Special Challenges in HL

  • Magnus Björkholm
  • Teodoro Chisesi

  • WS Report on Non-Western Countries

    • James Armitage

  • WS Report on HL Treatment of Adolescents

    • Joseph Connors

  • WS Report on NLPHL

    • Michele Ghielmini

  • Hodgkin Lymphoma and HIV Infection (HD- HIV): Prognostic Factors in 596 Patients (Pts) within the European Group for the Study of HIV and Tumours

    • Michele Spina

  • Feasibility and Ef cacy of ABVD in Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11)

    • Boris Böll

  • Autologous Stem Cell Transplantation for Adolescents and Young Adults with Relapsed or Refractory Hodgkin Lymphoma

    • Michael Crump

16:00 – 17:30

Room: Großer Saal

Scientific Session Survivorship

  • Franco Cavalli
  • Volker Diehl

  • WS Report on Follow-Up Recommendations

    • John Raemaekers

  • Long-Term Outcome of Children and Adolescents

    • Kara Kelly

  • Quality of Life in HL

    • Peter Borchmann

  • A Comprehensive Prospective National Database to Enhance Breast Cancer (BC) Screening Services for Hodgkin Lymphoma (HL) Survivors Treated with Supradiaphragmatic Radiotherapy (SRT) in England

    • Sache Howell

  • A Prospective Study of Breast Magnetic Resonance Imaging (MRI) and Mammographic Screening in Long-Term Female Hodgkin Lymphoma (HL) Survivors

    • Andrea Ng

  • Coronary Artery Disease in Patients Treated for Hodgkin Lymphoma: Preliminary Results Using Computed Angiography Tomography

    • Theodore Girinsky

18:00 – 19:00

Room: Großer Saal

Satellite Symposium New Aspects of Lymphoma Therapy

  • Peter Borchmann
  • Robert Marcus

  • Mantle Cell Lymphoma – Quo Vadis?

    • Georg Heß

  • Follicular Lymphoma – Bortezomib in the Relapsed/Refractory Setting

    • Mathias Rummel

Archive

You a viewing the program of a past symposium. Click here to get back to the current conference.